EMLAX | FSEDX | EMLAX / FSEDX | |
Total Expense Ratio | 1.10 | 0.00 | - |
Annual Report Gross Expense Ratio | 1.26 | 0.02 | 6,300% |
Fund Existence | 14 years | 5 years | - |
Gain YTD | 12.397 | 12.515 | 99% |
Front Load | 4% | N/A | - |
Min. Initial Investment | 1000 | 0 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 470M | 454M | 104% |
Annual Yield % from dividends | 4.56 | 4.28 | 107% |
Returns for 1 year | 11.86 | 12.03 | 99% |
Returns for 3 years | 28.95 | 32.31 | 90% |
Returns for 5 years | 13.54 | N/A | - |
Returns for 10 years | 23.58 | N/A | - |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
FXP | 10.80 | 0.31 | +2.91% |
ProShares UltraShort FTSE China 50 | |||
MGOV | 20.06 | 0.11 | +0.53% |
First Trust Intermediate Gvt Opps ETF | |||
BSMR | 23.56 | 0.01 | +0.02% |
Invesco BulletShares 2027 Muncpl Bd ETF | |||
LIAO | 209.51 | N/A | N/A |
LifeX 2056 Infl-Prt Longevity Inc ETF | |||
BBEM | 58.16 | -0.12 | -0.21% |
JPMorgan BetaBuilders Emerging Mkt EqETF |